Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology-Basic: Radiopharmaceutical Therapy

Megalin is essential for the kidney uptake of In-111-labeled peptides: Studies in megalin-deficient mice

Erik Vegt, Marleen Melis, Annemarie Eek, Monique De Visser, Wim Oyen, Marion De Jong and Otto Boerman
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1159;
Erik Vegt
1Nucl.Med., MUMC, Maastricht, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marleen Melis
3Nucl.Med., Erasmus MC, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annemarie Eek
2Nucl.Med., Radboud University MC, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monique De Visser
3Nucl.Med., Erasmus MC, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim Oyen
2Nucl.Med., Radboud University MC, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marion De Jong
3Nucl.Med., Erasmus MC, Rotterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Otto Boerman
2Nucl.Med., Radboud University MC, Nijmegen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint

    Renal Uptake of Radiolabeled Peptides

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Megalin is essential for the kidney uptake of In-111-labeled peptides: Studies in megalin-deficient mice
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Megalin is essential for the kidney uptake of In-111-labeled peptides: Studies in megalin-deficient mice
Erik Vegt, Marleen Melis, Annemarie Eek, Monique De Visser, Wim Oyen, Marion De Jong, Otto Boerman
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1159;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Megalin is essential for the kidney uptake of In-111-labeled peptides: Studies in megalin-deficient mice
Erik Vegt, Marleen Melis, Annemarie Eek, Monique De Visser, Wim Oyen, Marion De Jong, Otto Boerman
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1159;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology-Basic: Radiopharmaceutical Therapy

  • Results of a phase I/II dose-finding and efficacy study of the tumor-targeting 131I-L19SIP human recombinant mini-antibody in patients (pts) with cancer
  • Iodide-131 humanized monoclonal antibody to CD 25 in relapsed Hodgkin’s lymphoma - First results in compassionate use
  • Peptide receptor radionuclide therapy (PRRT) of treatment-refractory metastatic thyroid cancer using Yttrium-90 and Lutetium-177 labeled somatostatin analogs: Toxicity, response and survival analysis
Show more Oncology-Basic: Radiopharmaceutical Therapy

Oncology: Radiopharmaceutical Therapy Posters

  • Deposition of Yttrium-90 microspheres (Y-90) in the gastroduodenum (GD) is associated with early stasis/reflux and likely caused by reflux to the gastroduodenal artery (GDA)
  • Therapeutic effect of biodegradable 32P-chromic phosphate-poly(l-lactide) seeds on human hepatocellular carcinoma in nude mice after intratumoral implantation
  • Radium-223 chloride, a first-in-class alpha-pharmaceutical for patients with castration resistant prostate cancer (CRPC) and bone metastases. Dosimetry and pharmacokinetic analysis
Show more Oncology: Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire